Cryoport, Inc. (CYRX) compared with its closest peers (PHAT, SNDX, MRVI, RYTM, HRTX). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Phathom Pharmaceuticals, Syndax Pharmaceuticals, Maravai LifeSciences, Rhythm Pharmaceuticals, Heron Therapeutics, MacroGenics, Karyopharm Therapeutics, Vanda Pharmaceuticals, IDEAYA Biosciences and Puma Biotechnology share Cryoport's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Phathom Pharmaceuticals, Inc. (PHAT) | $718.00M | -5.5 |
| Syndax Pharmaceuticals, Inc. (SNDX) | $1.74B | -6.4 |
| Maravai LifeSciences Holdings, Inc. (MRVI) | $1.28B | -3.6 |
| Rhythm Pharmaceuticals, Inc. (RYTM) | $7.57B | -34.4 |
| Heron Therapeutics, Inc. (HRTX) | $64.55M | -10.8 |
| MacroGenics, Inc. (MGNX) | $257.35M | -1.4 |
| Karyopharm Therapeutics Inc. (KPTI) | $44.57M | -0.4 |
| Vanda Pharmaceuticals Inc. (VNDA) | $318.12M | -2.4 |
| IDEAYA Biosciences, Inc. (IDYA) | $3.83B | -27.0 |
| Puma Biotechnology, Inc. (PBYI) | $476.97M | 17.9 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
CYRX overview · CYRX earnings · CYRX financials · CYRX KPIs · CYRX documents · CYRX ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.